The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Next-generation sequencing of tissue and liquid rebiopsy favors post-progression outcomes of EGFR T790M-positive NSCLC patients treated with osimertinib.
 
Jiangtao Cheng
No Relationships to Disclose
 
YiHui Yao
No Relationships to Disclose
 
Yu-Er Gao
No Relationships to Disclose
 
Shi-Ling Zhang
No Relationships to Disclose
 
Hua-Jun Chen
No Relationships to Disclose
 
Zhen Wang
No Relationships to Disclose
 
Hong-Hong Yan
No Relationships to Disclose
 
Qing Zhou
Honoraria - AstraZeneca; Roche
 
Hai-Yan Tu
No Relationships to Disclose
 
Xu-Chao Zhang
No Relationships to Disclose
 
Jian Su
No Relationships to Disclose
 
Zhi Xie
No Relationships to Disclose
 
Yi-Long Wu
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche
Research Funding - Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst)
 
Jin-Ji Yang
No Relationships to Disclose